Shire

Auven Therapeutics pits rival PhIII dry eye drug against Allergan, Shire
Fierce Biotech
Fri, 11/13/15 - 11:01 am
Auven Therapeutics
dry eye disease
Seciera
Restasis
Allergan
Shire
Lifitegrast
$5.9 Billion Buyout: 1 Number Underpins Shire's Huge Dyax Bet
Motley Fool
Sat, 11/7/15 - 12:45 pm
M&A
Dyax
Shire
Shire to Acquire Dyax for $5.9 Billion to Bolster Rare Disease Drug Business
TheStreet.com
Mon, 11/2/15 - 08:10 am
Shire
Dyax
M&A
The top 10 biopharma pipeline disasters of 2015
Fierce Biotech
Fri, 10/30/15 - 09:55 am
Eli Lilly
GSK
AstraZeneca
Shire
Celladon
Takeda
Merck
Roche
Verastem
evacetrapib
Breo Ellipta
brodalumab
selumetinib
SHP625
Mydicar
Alisertib
suggammadex
sembragiline
Defactinib
Why Baxalta Earnings Beat Makes Shire Deal Doubtful
Bidness, ETC
Fri, 10/30/15 - 09:50 am
Baxalta
Shire
earnings
M&A
Shire says its once-rejected eye drug is back on track with a Phase III success
Fierce Biotech
Tue, 10/27/15 - 09:42 am
Shire
Lifitegrast
dry eye disease
Shire Vows to Pursue Baxalta Deal as Profit Beats Estimates
Bloomberg
Fri, 10/23/15 - 09:21 am
Shire
Baxalta
innovation
earnings
Shire Aims to Refile Blockbuster Eye Drug in First Quarter
Bloomberg
Mon, 10/19/15 - 09:59 am
Shire
dry eye disease
Lifitegrast
FDA eye drug rebuff adds to Shire's woes in Baxalta pursuit
Yahoo/Reuters
Sat, 10/17/15 - 03:10 pm
FDA
Lifitegrast
Shire
Baxalta
M&A
3 ADHD Treatment Makers to Watch
Motley Fool
Mon, 10/12/15 - 08:49 am
ADHD
Shire
JNJ
Eli Lilly
3 Big Drugs Likely To Hit The Market Soon
Investors.com
Wed, 09/30/15 - 04:56 pm
Merck
Keytruda
Shire
Lifitegrast
Gilead Sciences
Genvoya
Shire chalks up victory in Vyvanse patent battle
Fierce Pharma
Fri, 09/25/15 - 08:47 pm
Shire
Vyvanse
patents
ADHD
generics
Shire's once-daily extended-release ADHD drug now approved in Europe
BioPharma Dive
Tue, 09/22/15 - 11:35 am
Shire
ADHD
Intuniv
Europe
Baxalta executive says will not do defensive M&A
Yahoo/Reuters
Thu, 09/17/15 - 09:54 am
Baxalta
M&A
Shire
Pharma Deal-Making: In The Pink Of Health
Seeking Alpha
Wed, 09/16/15 - 10:26 am
M&A
Baxalta
GSK
JNJ
Eli Lilly
Novartis
Perrigo
Shire
Shire PLC, Baxalta Inc: Investors’ Reactions To Higher Bid Reports
Bidness, ETC
Tue, 09/15/15 - 11:37 am
Shire
Baxalta
investors
M&A
Shire weighs options to sweeten all-stock offer for Baxalta
Marketwatch
Mon, 09/14/15 - 08:13 am
Shire
Baxalta
M&A
Will Shire Sweeten Its Takeover Offer For Baxalta Inc?
Bidness, ETC
Thu, 09/3/15 - 07:58 am
Shire
Baxalta
M&A
Shire and Sangamo break up their gene-editing partnership
Fierce Biotech
Wed, 09/2/15 - 12:39 pm
Shire
Sangamo
gene editing
Baxalta may have a new M&A-based strategy for spurning Shire
BioPharma Dive
Tue, 09/1/15 - 06:45 pm
Shire
Baxalta
M&A
Ariad Pharma

Pages